Desensitizing Distressing Recollections in Cancer Patients
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/15/2018 |
Start Date: | April 11, 2010 |
End Date: | September 28, 2017 |
The major goal of this study is to determine whether Neuro-Emotional Technique is a viable
treatment option for decreasing distress in cancer patients. The potential advantages of NET
are: 1) it is designed specifically to address distressing stimuli and unresolved emotional
memories; 2) it is a brief, time-limited intervention; and 3) its multi-modal design may
appeal to and benefit a broader range of patients than a single mode intervention
treatment option for decreasing distress in cancer patients. The potential advantages of NET
are: 1) it is designed specifically to address distressing stimuli and unresolved emotional
memories; 2) it is a brief, time-limited intervention; and 3) its multi-modal design may
appeal to and benefit a broader range of patients than a single mode intervention
Inclusion Criteria:
- Age ≥18 years of age
- Distressing cancer-related recollection that has persisted for at least six months
- Distressing cancer-related recollection that causes physiological reactivity (i.e.,
increased heart rate and/or increased skin conductance level - SCL), as described in
section 4.2.3.
- Received a cancer diagnosis at least 6 months prior to being contacted for
participation in this study
Exclusion Criteria:
- Any current Major Mental Disorder, as assessed by Structured Clinical Interview for
DSM IV Axis I Disorders (SCID - Clinical Version, First et al, 1997)
- History of Post-traumatic Stress Disorder
- Current active mood primary disorder prior to the cancer diagnosis (as per PI or
designate)
- History or current diagnosis of substance or alcohol abuse or dependence (as per PI or
designate)
- Use of psychotropic medications within the past month or current use of medications
that would interfere with autonomic nervous system measures (benzodiazepines,
barbiturates, major tranquilizers).
- Use of some psychotropic medications are allowed such as SSRIs and certain sleep aids,
but dosages must be stable from six weeks prior to enrollment and throughout study
period
- Any psychological or musculoskeletal problems that would interfere with
psychophysiological assessments and treatment
- Currently receiving chemotherapy or radiation
- Are in the terminal stages of illness
We found this trial at
1
site
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials